天眼查App显示，近日，内江明瞳眼镜有限公司成立，法定代表人为李萍，注册资本1万人民币，经营 范围为一般项目：眼镜销售（不含隐形眼镜）；光学玻璃销售；健康咨询服务（不含诊疗服务）；康复 辅具适配服务；租赁服务（不含许可类租赁服务）；第二类医疗器械销售；第二类医疗设备租赁；第一 类医疗器械销售；养生保健服务（非医疗）；保健食品（预包装）销售；食品销售（仅销售预包装食 品）；日用百货销售；日用品销售；办公用品销售；五金产品零售；家用电器销售。（除依法须经批准 的项目外，凭营业执照依法自主开展经营活动）许可项目：第三类医疗器械经营。（依法须经批准的项 目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）（涉及 国家规定实施准入特别管理措施的除外）。 ...

Group 1 - The stock price of Dr. Optical fell by 5.06% to 28.31 yuan per share, with a trading volume of 145 million yuan and a turnover rate of 3.22%, resulting in a total market capitalization of 6.451 billion yuan [1] - Dr. Optical, established on April 23, 1997, and listed on March 15, 2017, is primarily engaged in optical retail, with revenue composition as follows: optical glasses and fitting services 68.65%, finished glasses series products 19.47%, contact lenses series products 10.80%, and others 1.09% [1] Group 2 - Minsheng Jia Yin Fund's Minsheng Jia Yin Sustained Growth Mixed A (007731) is among the top ten circulating shareholders of Dr. Optical, having increased its holdings by 418,700 shares to a total of 1.9187 million shares, representing 1.23% of circulating shares [2] - The fund has incurred an estimated floating loss of approximately 2.8972 million yuan as of the report date [2] - Minsheng Jia Yin Sustained Growth Mixed A was established on September 24, 2019, with a current scale of 1.394 billion yuan, achieving a year-to-date return of 25.57% and a one-year return of 23.58% [2] Group 3 - The fund manager of Minsheng Jia Yin Sustained Growth Mixed A is Zhu Chenzhe, who has been in position for 3 years and 343 days, with a total asset scale of 1.792 billion yuan and a best fund return of 10.8% during his tenure [3] - Co-manager Fan Mingyue has been in position for 306 days, managing assets totaling 1.857 billion yuan, with a best fund return of 26.53% during his tenure [3]

Group 1 - Shanghai Baojing Island Glasses Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The legal representative of the company is Huang Hai [1] - The business scope includes general projects such as glasses sales (excluding contact lenses), lens processing, optical instrument sales, optical glass sales, and rehabilitation aid adaptation services [1] Group 2 - The company is authorized to operate third-class medical devices, subject to approval from relevant authorities [1] - The company can conduct business activities independently based on its business license, except for projects that require legal approval [1]

Core Insights - Shanghai Puliao Optical Co., Ltd. has been established with a registered capital of 500,000 RMB [1] - The company is engaged in the sale of glasses (excluding contact lenses) and the sale of Class II medical devices [1] - The company is also involved in the leasing of Class III medical equipment, which requires approval from relevant authorities [1] Business Scope - General projects include the sale of glasses, cosmetics retail, personal hygiene products sales, daily miscellaneous goods sales, Class I medical devices sales, and electronic products sales [1] - The company operates under a business license and can independently conduct business activities not requiring prior approval [1] - Specific business activities are subject to approval and must comply with relevant departmental regulations [1]

Core Viewpoint - Dr. Optical's stock price increased by 5.11% to 31.66 CNY per share, with a trading volume of 279 million CNY and a turnover rate of 5.93%, resulting in a total market capitalization of 7.214 billion CNY [1] Group 1: Company Overview - Dr. Optical Chain Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on April 23, 1997, with its listing date on March 15, 2017 [1] - The company's main business involves optical retail, with revenue composition as follows: optical glasses and fitting services 68.65%, finished glasses series products 19.47%, contact lens series products 10.80%, and others 1.09% [1] Group 2: Shareholder Information - Minsheng Jia Yin Fund's Minsheng Jia Yin Sustained Growth Mixed A (007731) is among the top ten circulating shareholders of Dr. Optical, having increased its holdings by 418,700 shares to a total of 1.9187 million shares, representing 1.23% of circulating shares [2] - The fund has achieved a year-to-date return of 28.25%, ranking 2995 out of 8140 in its category, and a one-year return of 25.27%, ranking 3257 out of 8057 [2] Group 3: Fund Manager Performance - The fund manager Zhu Chenzhe has been in position for 3 years and 340 days, managing assets totaling 1.792 billion CNY, with the best fund return during his tenure at 10.69% and the worst at -7.37% [3] - Co-manager Fan Mingyue has been in position for 303 days, managing assets of 1.857 billion CNY, with the best fund return at 26.02% and the worst at -3.15% [3]

Core Viewpoint - Chengdu Tianqi Xiaoyanjing Co., Ltd. has been established with a registered capital of 500,000 RMB, indicating a new player in the optical and healthcare market [1] Company Overview - The legal representative of the company is Yang Xuecong [1] - The company is involved in a wide range of business activities, including the sale of glasses (excluding contact lenses), internet sales, and various medical and health-related products [1] Business Scope - The company’s business scope includes: - General projects: sales of glasses, internet sales (excluding licensed goods), sales of second-class medical devices, sales of pre-packaged health foods, sales of optical glass, and health services (non-medical) [1] - Sales of first-class medical devices, daily necessities, personal hygiene products, and various retail and wholesale activities [1] - Consulting services in health, technology, and business management, as well as marketing planning and supply chain management [1] - The company is also authorized to engage in the rental of medical equipment and retail of pharmaceuticals, subject to regulatory approval [1]

Core Viewpoint - Shanghai Xingjingjie Glasses Co., Ltd. has been established with a registered capital of 100,000 RMB, indicating a new player in the eyewear market [1] Company Overview - The legal representative of the company is Zhang Jiamei [1] - The company is engaged in a wide range of business activities including the sale of glasses (excluding contact lenses), watches, jewelry, and various retail and wholesale services [1] Business Scope - The business scope includes general projects such as: - Eyewear sales (excluding contact lenses) - Watch sales - Retail and wholesale of jewelry [1] - Retail of photographic equipment and telescopes [1] - Sale of stationery and daily necessities [1] - Retail and wholesale of arts and crafts [1] - Computer hardware and software sales [1] - Internet sales (excluding licensed goods) [1] - Data processing and storage support services [1] - Equipment leasing services [1] - Advertising design and agency services [1] - Technical services and consulting [1] - Import and export of goods [1]

Core Viewpoint - Mingyue Lens, a leading lens brand in China, collaborates with Qianye Glasses to launch a campus public welfare campaign aimed at promoting vision health among children and adolescents, addressing the rising myopia rates in the country [1][5][8] Group 1: Campaign Overview - The campaign titled "Climbing to the Peak and Building Dreams for a Voyage" involves sharing learning experiences and myopia prevention knowledge with students in Chongqing [1] - Tsinghua University student leader Zhang Zhiyuan participated in the event, providing practical study techniques and encouraging students to adopt healthy eye care practices [1][3] Group 2: Myopia Statistics and Importance - According to the National Health Commission, the overall myopia rate among children and adolescents in China is projected to reach 52.7% by 2024, indicating that one in two students is affected [5] - The significance of myopia prevention is underscored by the alarming statistics, prompting initiatives like the public welfare campaign [5] Group 3: Product Offering - Mingyue Lens offers the "Mingyue Easy Control Lens," designed specifically for Chinese children's eye habits, balancing prevention effectiveness and comfort [5] - Clinical trials conducted by Zhongshan Ophthalmic Center and Tianjin Eye Hospital show that the lens has a myopia progression control effectiveness rate of 73.82%, with results published in the international journal "Ophthalmology" [5] Group 4: Social Responsibility - As a national brand, Mingyue Lens emphasizes its social responsibility by promoting myopia prevention awareness across the country, advocating for the protection of children's vision as a means to secure a brighter future [8]

Group 1 - The provincial market supervision bureau conducted quality supervision sampling on 24 types of products, including toys, adult diapers, prescription glasses, and reading glasses, with a total of 1204 batches [1] - Among the sampled products, 41 batches from 40 distribution units were found to be non-compliant, resulting in a non-compliance rate of 4.2%, while 4 batches from 4 manufacturing enterprises had a non-compliance rate of 1.7% [1] Group 2 - Specific non-compliance was noted in 3 batches of prescription glasses from companies such as Shenyang Dapeng Trading Co., Ltd., with a non-compliance rate of 10%, primarily due to issues with cylindrical axis deviation and spherical focal power deviation [1] - In the case of reading glasses, 5 batches from various retailers, including Benxi Chunfeng Trading Center and Panjin Zhongxing Glasses Co., Ltd., exhibited a non-compliance rate of 25%, with detected issues including spherical focal power deviation and optical center deviation [1]

Core Insights - Shanghai Zhongxia Glasses Co., Ltd. has been established with a registered capital of 100,000 RMB, and its legal representative is Wei Zhongxia [1] Company Overview - The company operates in various sectors including the sale of glasses (excluding contact lenses), optical instruments, cosmetics, hardware products, home appliances, clothing and accessories, footwear, daily necessities, arts and crafts, first and second-class medical devices, pre-packaged food, and wellness services (non-medical) [1] - The company is also involved in the operation of third-class medical devices, which requires approval from relevant authorities before commencing business activities [1]